Thin melanoma

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 3, 2011, Pages 342-346

  Elder, David E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CANCER INVASION; CANCER STAGING; FEMALE; HUMAN; MALE; MELANOMA; METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; SKIN TUMOR; SURVIVAL RATE;

FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 79952923955     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Petersen NC, Bodenham DC, Lloyd OC. Malignant melanomas of the skin. Brit J Plastic Surg. 1962; 15:49-94.
2. Mehnert JH, Heard JL. Staging of malignant melanoma by depth of invasion. Am J Surg. 1965;110:168-176.
3. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Montagna W, Hu F, eds. Advances in the Biology of the Skin. Vol VIII. New York, NY: Pergamon Press; 1967:621-647.
4. Clark WH Jr, From L, Bernardino EA, Mihm MC Jr. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29(3):705-527.
5. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970; 172(5):902-908.
6. Weinstock MA. Progress and prospects on melanoma: the way forward for early detection and reduced mortality. Clin Cancer Res. 2006;12(7, pt 2):2297s-2300s.
7. Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg. 1975;182(5):572-575.
8. Breslow A, Macht SD. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet. 1977;145(5):691-692. (Pubitemid 8225365)
9. Balch CM, Murad TM, Soong SJ, et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer. 1979;43(3): 883-888. (Pubitemid 9163616)
10. Elder DE, Guerry DIV, Heiberger RM, et al. Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg. 1983;71(1):66-72. (Pubitemid 13179431)
11. Elder DE, Guerry DIV, VanHorn M, et al. The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer. 1985;56(2):413-418. (Pubitemid 15031668)
12. Elder DE, Guerry D, Epstein MN, et al. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol. 1984;(6)(suppl):55-61. (Pubitemid 15207023)
13. Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22(18):3668-3676. (Pubitemid 41095205)
14. Gimotty PA, Van BP, Elder DE, et al. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol. 2005;23(31):8048-8056. (Pubitemid 46657407)
15. Clark WH Jr, Elder DE, Guerry DIV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24): 1893-1904. (Pubitemid 20026075)
16. Elder DE, Guerry DIV, Epstein MN, et al. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol. 1984;(6)(suppl):55-62.
17. Elder DE, Murphy GF. Malignant tumors (melanomas and related lesions). In: Elder DE, Murphy GF, eds. Melanocytic Tumors of the Skin. Washington, DC: Armed Forces Institute of Pathology; 1991:103-206. Atlas of Tumor Pathology. 3rd series, fascicle 2.
18. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648. (Pubitemid 32786276)
19. Gimotty PA, Botbyl J, Soong SJ, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2005;23(31):8065-8075. (Pubitemid 46657409)
20. Cochran AJ. Method of assessing prognosis in patients with malignant melanoma. Lancet. 1968,2(7577): 1062-1064.
21. Schmoeckel C, Braun-Falco O. Prognostic index in maligant melanoma. Arch Dermatol. 1978;114(6):871-873.
22. Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer. 2003,97(6): 1488-1498. (Pubitemid 36297779)
23. Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol. 2003;27(12):1571-1576. (Pubitemid 37486620)
24. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
25. Gimotty PA, Elder DE, Fraker DL, et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol. 2007; 25(9): 1129-1134. (Pubitemid 46596766)
26. Puleo CA, Messina JL, Riker Al, et al. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control. 2005; 12(4): 230-235. (Pubitemid 41552314)
27. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004; 11(3):247-258. (Pubitemid 40486764)
28. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochem-ical characteristics of melanoma. J Cutan Pathol. 2008;35(5):433-444.
29. Pearl RA, Pacifico MD, Richman Pl, et al. Ki-67 expression in melanoma: a potential method of risk assessment for the patient with a positive sentinel node. J Exp Clin Cancer Res. 2007;26(1):109-115. (Pubitemid 46650051)
30. Kreizenbeck GM, Berger AJ, Subtil A, et al. Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2008;17(4):949-958. (Pubitemid 351536428)
31. Feldman MD. Beyond morphology: whole slide imaging, computer-aided detection, and other techniques. Arch Pathol Lab Med. 2008;132(5):758-763. (Pubitemid 351632849)
32. Feldman MD. Beyond morphology: whole slide imaging, computer-aided detection, and other techniques. Arch Pathol Lab Med. 2008;58(36):997-1001.